Skip to main content

Published locations for Nemolizumab improved most common symptoms in moderate, severe atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Nemolizumab improved most common symptoms in moderate, severe atopic dermatitis

User login

  • Reset your password
  • /content/nemolizumab-improved-most-common-symptoms-moderate-severe-atopic-dermatitis
  • /edermatologynews/article/107327/atopic-dermatitis/nemolizumab-improved-most-common-symptoms-moderate
  • /familypracticenews/article/107327/atopic-dermatitis/nemolizumab-improved-most-common-symptoms
  • /internalmedicinenews/article/107327/atopic-dermatitis/nemolizumab-improved-most-common-symptoms
  • /internalmedicine/article/107327/atopic-dermatitis/nemolizumab-improved-most-common-symptoms-moderate
  • /dermatology/article/107327/atopic-dermatitis/nemolizumab-improved-most-common-symptoms-moderate
  • /familymedicine/article/107327/atopic-dermatitis/nemolizumab-improved-most-common-symptoms-moderate